RoMEA Rapid Diagnostic Tests (RDT) Market to 2032
Overview
The RoMEA Rapid Diagnostic Tests (RDT) Market is expected to reach a 315.16 USD Million by 2032 and is projected to grow at a CAGR of 5.98% from 2025 to 2032.
Revenue, 2024 (USD Million)
220.66
Forecast, 2032 (USD Million)
315.16
CAGR, 2024 - 2032
5.98%
Report Coverage
RoMEA
RoMEA Rapid Diagnostic Tests (RDT) Market 2018-2032 USD Million
RoMEA Rapid Diagnostic Tests (RDT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 220.66 USD Million
- Projected Market Size (2032): 315.16 USD Million
- CAGR (2025-2032): 5.98%
Key Findings of RoMEA Rapid Diagnostic Tests (RDT) Market
- The RoMEA Rapid Diagnostic Tests (RDT) Market was valued at 220.66 USD Million in 2024.
- The RoMEA Rapid Diagnostic Tests (RDT) Market is likely to grow at a CAGR of 5.98% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Adult in Age Group Segment accounted for the largest share of the market with a revenue of 188.14 USD Million
- The fastest growing segment Determining Confirmation in Test Type Segment grew Fastest with a CAGR of 8.33% during the forecast period from 2024 to 2032.
RoMEA Rapid Diagnostic Tests (RDT) Market Scope
RoMEA Rapid Diagnostic Tests (RDT) Market Segmentation & Scope
Age Group
- Pediatric
- Adult
Modality
- Non-Laboratory Based Test
- Laboratory Based Test
Technology
- Others
- Substrate Technology
- Microfluidics
- Agglutination Assay
- Lateral Flow Immunochromatographic Assays
- Flow-Through Assays
- PCR-Based
Test Type
- Viral Sequencing
- Serological Testing
- Determining Confirmation
Approach
- Molecular Diagnostic
- In-Vitro Diagnostic
Mode
- Over-the-Counter
- Professional
Product Type
- Others
- Instruments
- Consumables and Kits
Specimen
- Others
- Sputum
- Saliva
- Urine
- Blood
- Swab
Application
- Others
- Toxicology Testing
- Pregnancy & Fertility Testing
- Drugs-Of-Abuse Testing
- Cardiometabolic Testing
- Oncology Testing
- Cardiology Testing
- Glucose Monitoring
- Infections Disease Testing
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Research And Academic Institutes
- Home Care Setting
- Others
- Diagnostic Laboratory
- Hospital & Clinic
RoMEA Rapid Diagnostic Tests (RDT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 220.66 USD Million |
| Market Value in 2032 | 315.16 USD Million |
| CAGR (2025-2032) | 5.98% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Age Group, Modality, Technology, Test Type, Approach, Mode, Product Type, Specimen, Application, Distribution Channel, End User |
Regional Insights:
-
Leading Market (2024-2032): RoMEA, leading in terms of revenue 220.66 USD Million in 2024
- Key Country: RoMEA, leading in terms of revenue with value of 220.66 USD Million in 2024.
Segments and Scope
-
RoMEA Rapid Diagnostic Tests (RDT) Market to 2032, By Age Group
- Adult is the largest segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 188.14 USD Million in the year 2024.
- Adult is the Fastest growing segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 6.01 % in forecast period 2025-2032.
-
RoMEA Rapid Diagnostic Tests (RDT) Market to 2032, By Modality
- Laboratory Based Test is the largest segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 160.66 USD Million in the year 2024.
- Laboratory Based Test is the Fastest growing segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 6.31 % in forecast period 2025-2032.
-
RoMEA Rapid Diagnostic Tests (RDT) Market to 2032, By Technology
- PCR-Based is the largest segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 87.27 USD Million in the year 2024.
- PCR-Based is the Fastest growing segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 7.69 % in forecast period 2025-2032.
-
RoMEA Rapid Diagnostic Tests (RDT) Market to 2032, By Test Type
- Determining Confirmation is the largest segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 100.95 USD Million in the year 2024.
- Determining Confirmation is the Fastest growing segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 8.33 % in forecast period 2025-2032.
-
RoMEA Rapid Diagnostic Tests (RDT) Market to 2032, By Approach
- In-Vitro Diagnostic is the largest segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 164.37 USD Million in the year 2024.
- In-Vitro Diagnostic is the Fastest growing segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 6.45 % in forecast period 2025-2032.
-
RoMEA Rapid Diagnostic Tests (RDT) Market to 2032, By Mode
- Professional is the largest segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 169.54 USD Million in the year 2024.
- Professional is the Fastest growing segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 6.25 % in forecast period 2025-2032.
-
RoMEA Rapid Diagnostic Tests (RDT) Market to 2032, By Product Type
- Consumables and Kits is the largest segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 130.29 USD Million in the year 2024.
- Consumables and Kits is the Fastest growing segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 7.33 % in forecast period 2025-2032.
-
RoMEA Rapid Diagnostic Tests (RDT) Market to 2032, By Specimen
- Swab is the largest segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 102.19 USD Million in the year 2024.
- Swab is the Fastest growing segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 7.52 % in forecast period 2025-2032.
-
RoMEA Rapid Diagnostic Tests (RDT) Market to 2032, By Application
- Infections Disease Testing is the largest segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 81.58 USD Million in the year 2024.
- Infections Disease Testing is the Fastest growing segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 8.24 % in forecast period 2025-2032.
-
RoMEA Rapid Diagnostic Tests (RDT) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 145.82 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 6.69 % in forecast period 2025-2032.
-
RoMEA Rapid Diagnostic Tests (RDT) Market to 2032, By End User
- Hospital & Clinic is the largest segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 124.53 USD Million in the year 2024.
- Hospital & Clinic is the Fastest growing segment in RoMEA Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 6.68 % in forecast period 2025-2032.
RoMEA Rapid Diagnostic Tests (RDT) Market Company Share Analysis
| Company Name |
|
||
| PerkinElmer Inc. | |||
| Quidel Corporation | |||
| Bio-Rad Laboratories, Inc. | |||
| Cardinal Health | |||
| Abbott | |||
RoMEA Rapid Diagnostic Tests (RDT) Market Geographical Sales Distribution, 2018-2032 USD Million
RoMEA Rapid Diagnostic Tests (RDT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoMEA Rapid Diagnostic Tests (RDT) Market is segmented based on Segmentation Age Group, Modality, Technology, Test Type, Approach, Mode, Product Type, Specimen, Application, Distribution Channel, End User.
RoMEA Rapid Diagnostic Tests (RDT) Market was valued at USD 220.66(Revenue in USD Million) in 2020.
RoMEA Rapid Diagnostic Tests (RDT) Market is projected to grow at a CAGR of 5.98% during the forecast period of 2024 to 2032.
The Adult segment is expected to dominate the RoMEA Rapid Diagnostic Tests (RDT) Market, holding a largest market share of 188.14 USD Million in 2024
Coming Soon....
RoMEA Rapid Diagnostic Tests (RDT) Market Scope
RoMEA Rapid Diagnostic Tests (RDT) Market Segmentation & Scope
Age Group
- Pediatric
- Adult
Modality
- Non-Laboratory Based Test
- Laboratory Based Test
Technology
- Others
- Substrate Technology
- Microfluidics
- Agglutination Assay
- Lateral Flow Immunochromatographic Assays
- Flow-Through Assays
- PCR-Based
Test Type
- Viral Sequencing
- Serological Testing
- Determining Confirmation
Approach
- Molecular Diagnostic
- In-Vitro Diagnostic
Mode
- Over-the-Counter
- Professional
Product Type
- Others
- Instruments
- Consumables and Kits
Specimen
- Others
- Sputum
- Saliva
- Urine
- Blood
- Swab
Application
- Others
- Toxicology Testing
- Pregnancy & Fertility Testing
- Drugs-Of-Abuse Testing
- Cardiometabolic Testing
- Oncology Testing
- Cardiology Testing
- Glucose Monitoring
- Infections Disease Testing
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Research And Academic Institutes
- Home Care Setting
- Others
- Diagnostic Laboratory
- Hospital & Clinic
Frequently Asked Questions
The RoMEA Rapid Diagnostic Tests (RDT) Market is segmented based on Segmentation Age Group, Modality, Technology, Test Type, Approach, Mode, Product Type, Specimen, Application, Distribution Channel, End User.
RoMEA Rapid Diagnostic Tests (RDT) Market was valued at USD 220.66(Revenue in USD Million) in 2020.
RoMEA Rapid Diagnostic Tests (RDT) Market is projected to grow at a CAGR of 5.98% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Rapid Diagnostic Tests (RDT) Market for final year is USD 315.16 (USD Million).
RoMEA Rapid Diagnostic Tests (RDT) Market Company Profiling
Frequently Asked Questions
The RoMEA Rapid Diagnostic Tests (RDT) Market is segmented based on Segmentation Age Group, Modality, Technology, Test Type, Approach, Mode, Product Type, Specimen, Application, Distribution Channel, End User.
RoMEA Rapid Diagnostic Tests (RDT) Market was valued at USD 220.66(Revenue in USD Million) in 2020.
RoMEA Rapid Diagnostic Tests (RDT) Market is projected to grow at a CAGR of 5.98% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Rapid Diagnostic Tests (RDT) Market for final year is USD 315.16 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.